Effect of pharmacological treatment of depression on A1C and quality of life in low-income hispanics and African Americans with diabetes: A randomized, double-blind, placebo-controlled trial

Diabetes Care

Volumn 32, Issue 12, 2009, Pages 2156-2160

  Echeverry, Diana ^a   Duran, Petra ^a   Bonds, Curley ^a   Lee, Martin ^a   Davidson, Mayer B ^a  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; PLACEBO; SERTRALINE;

AFRICAN AMERICAN; ALGORITHM; ARTICLE; CLINICAL TRIAL; COMPUTER PROGRAM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIABETES MELLITUS; DIAGNOSTIC INTERVIEW SCHEDULE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG EFFECT; FEMALE; HAMILTON SCALE; HISPANIC; HUMAN; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; NURSE; PAIN ASSESSMENT; PATIENT COMPLIANCE; PREDICTION; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RASH; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION;

AFRICAN CONTINENTAL ANCESTRY GROUP; ANTIDEPRESSIVE AGENTS; ANXIETY; BLOOD PRESSURE; BODY WEIGHT; CHOLESTEROL, LDL; DEPRESSION; DIABETES COMPLICATIONS; DOUBLE-BLIND METHOD; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HISPANIC AMERICANS; HUMANS; MALE; PLACEBOS; PREDICTIVE VALUE OF TESTS; QUALITY OF LIFE; QUESTIONNAIRES; SERTRALINE; SEXUAL BEHAVIOR;

EID: 72249089987     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc09-0785     Document Type: Article

References (25)

1. Anderson S, Freedland K, Clouse R, Lustman P. The prevalence of co-morbid depression in adults with diabetes. Diabetes Care 2001;24:1069-1077 (Pubitemid 33716379)
2. Lustman P, Anderson R, Freedland K, Groot MD, Carney R, Clouse R. Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 2000;23:934-942 (Pubitemid 30480020)
3. Gonzalez J, Safran S, Cagliero E, Wexler D, Delahanty L, Wittenberg E, Blais M, Meigs J, Grant R. Depression, self care, and medication adherence in type 2 diabetes: relationships across the full range of symptom severity. Diabetes Care 2007;30:2222-2227 (Pubitemid 47359018)
4. Black SA, Markides KS, Ray LA. Depression predicts increased incidence of adverse health outcomes in Mexican Americans with type 2 diabetes. Diabetes Care 2003;26:2822-2828
5. Xuanping Z, Norris S, Gregg E, Cheng Y, Beckles G, Kahn H. Depressive symptoms and mortality among persons with and without diabetes. Am J Epidemiol 2005;161:652-660 (Pubitemid 40411093)
6. Simon G, Katon W, Lin E, Ludman E, Von Korff M, Ciechanowski P, Young B. Diabetes and depression as predictors of health care costs. Gen Hosp Psychiatry 2005;27:344-351
7. Wagner J, Tsimikas J, Abbot G, De Groot M, Heapy A. Racial and ethnic differences in diabetic patient-reported depression symptoms, diagnosis, and treatment. Diabetes Res Clin Pract 2007;75:119-122 (Pubitemid 44856021)
8. Black SA. Increase in Health Burden Associations with co-morbid depression in older diabetic Mexican Americans: results from the Hispanic Established Population for the Epidemiologic Study of the Elderly survey. Diabetes Care 1999;22:56-64
9. Kirk J, Passmore L, Bell R, Narayan KM, D'Agostino R, Arcury T, Quandt S. Disparities in A1C levels between Hispanic and non-Hispanic white adults with diabetes: a meta analytic analysis. Diabetes Care 2008;31:240-246 (Pubitemid 351213329)
10. Roy M, Roy A, Affouf M. Depression is a risk factor for poor glycemic control and retinopathy in African Americans with type 1 diabetes. Psychosom Med 2007;69:537-542 (Pubitemid 47205737)
11. Lustman PJ, Griffith LS, Clouse RE, Freedland KE, Eisen SA, Rubin EH, Carney RM, McGill JB. Effects of nortriptyline on depression and glucose regulation in diabetes: results of a double blind, placebo controlled trial. Psychosom Med 1997;59:241-250
12. Lustman P, Griffith L, Freedland K, Kissel S, Clouse R. Cognitive behavior therapy for depression in type 2 diabetes: a randomized, controlled trial. Ann Intern Med 1998;129:613-621 (Pubitemid 28480816)
13. Lustman P, Freedland K, Griffith L, Clouse R. Fluoxetine for depression in diabetes: a randomized double-blind placebo controlled trial. Diabetes Care 2000;23:618-623 (Pubitemid 30321540)
14. Williams JW, Katon W, Lin EHB, Noel PH, Worchel J, Cornell J, Harpole L, Fultz BA, Hunkeler E, Mika VS, Unutzer J, IMPACT Investigators: The effectiveness of depression care management on diabetes-related outcomes in older patients. Ann Intern Med 2004;140:1054-1056 (Pubitemid 38756683)
15. Katon WJ, van Korff M, Lin EHB, Simon G, Ludman E, Russo J, Ctechanowski P, Walker E, Bush T. The Pathways Study: a randomized trial of collaborative care in patients with diabetes and depression. Arch Gen Psychiatry 2004;61:1042-1049 (Pubitemid 39336538)
16. Lustman PJ, Clouse RE, Hirsh IB, Gelenberg AJ, Nix BD, Freedland KE. Sertraline for the prevention of depression recurrence in diabetes: a randomized, doubleblind, placebo controlled trial. Arch Gen Psychiatry 2006;63:521-529
17. Lustman P, Williams M, Sayuk G, Nix B, Clouse R. Factors influencing glycemic control in type 2 diabetes during acuteand maintenance phase treatment of major depressive disorder with bupropion. Diabetes Care 2007;30:459-466 (Pubitemid 46357400)
18. Paile-Hyvarinen M, Wahlbeck K, Eriksson J. Quality of life and metabolic status in mildly depressed patients with type 2 diabetes treated with paroxetine: a double- blind randomized placebo-controlled 6 month trial. BMC Fam Pract 2007;8:34-40 (Pubitemid 47052765)
19. Georgiades A, Zucker N, Friedman KE, Mosunic CJ, Applegate K, Lane JD, Feinglos MN, Surwit RS. Changes in depressive symptoms and glycemic control in diabetes mellitus. Psychosom Med 2007;69:235-241 (Pubitemid 46653075)
20. Snoek FJ, van der Ven NCW, Twisk JWR, Hogenelst MHE, Tromp-Wever AME, van der Ploeg HM, Heine RJ. Cognitive behavior therapy (CBT) compared with blood glucose awareness training (BGAT) in poorly controlled type 1 diabetic patients: long term effects on HbA1c moderated by depression: a randomized controlled trial. Diabetic Med 2008;25:1337-1342
21. Whooley MA, Avins AL, Miranda J. Case-finding instruments for depression: two questions are as good as many. J Gen Intern Med 1997;12:439-445 (Pubitemid 27300561)
22. Hamilton M. A rating scale for depression. J Neuro Neurosurg Psychiatry 1960;23:56-62
23. Davidson MB, Castellanos M, Duran P, Karlan V. Effective diabetes care by a registered nurse following treatment algorithms in a minority population. Am J Manag Care 2006;12:226-232
24. Boyer JG, Earp JA. The development of an instrument for assessing the quality of life of people with diabetes: Diabetes-39. Med Care 1997;35:440-453 (Pubitemid 127455044)
25. Gonzalez JS, Peyrot M, McCarl LAM, Collins EM, Serpa L, Mimiaga MJ, Safren S. Depression and diabetes treatment nonadherence: a meta-analysis. Diabetes Care 2008;31:2398-2403